Theralase Technologies Inc. V.TLT

New Press Release - Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study

TORONTO, ON / ACCESSWIRE / February 8, 2024 /Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the safe...read article.

[Infinity]

Great News indeed.  Perfect timing too.  Dr. Jewett is known all over the world and will be a huge jump in credibility when talking with FDA and Health Canada in additon to working the clinical sites.

[99942Apophis]

Dr. Micheal Jewett is like Dwayne Johnson but in the medical world!!!! 

[beenthere]

Talking about 2025, 2026, and 2027 is sure not going to bring in new investors.

[99942Apophis]

Hi beenthere, the timeline given in the news release is under regular time completion, if Theralase receives AA from the FDA they can go into immediate commercialization but they still will have to complete Phase2. I would guess TLT from past experience doesn't want to discuss earlier time frames before they are granted such.

[Tapps21]

Thoroughly read Dr Mandels comments which are very positive and  encouraging. Then, read DrJewetts  comments.  Also encouraging and supportive of Dr Mandel. I'm pretty sure a world renowned Dr would not join a small Canadian company if he didn't believe Theralase could provide a significant impact in the fight against cancer. And this is just one  indication (NMIBC

[Oilminerdeluxe]

Just what the doctor ordered.... Nice to see him back. I seem to recall him being very optimistic in a few old youtube clips

[Alamir1111]

Nice to have Dr Jewett back.

[enriquesuave]

Dr Jewett was involved in getting BCG FDA approved 30 years ago!  He is a recognized Key Opinion Leader worldwide.  Nice!  We also have Dr Kamat which is also on our board and also world renown.  Dr Kulkarni our principal Investigator is also top in Canada.  Big Pharma will know who to contact for DD.IMHO   

[Alamir1111]

We have an impressive line up of  world renowned  scientists  on board Dr Mandell Mcfarland  O'Donnell  Jewett Kamat Kulkarni Pavel Kasper list goes on .

[stocksnbonds458]

Having Dr Jewett back is a very good sign! IMO he is here to help get us over the hump with regards to enrollment, and wouldn't be doing so if he didn't think Theralase has a winner with Ruvidar. In other words, it's time to move this therapy through the bureaucracy and get it to market

[Rumpl3StiltSkin]

I think this Dr. Jewitt news, and BTD, will be very strong points for Dr. LBiati to use when she crafts a solid deal for TLT. GL everyone, very good news! :-) Hopefully very few PPs left...

[StevenBirch]

I went to the AGM in 2019 and he couldn't be there but spoke on video, nice man, very persuasive and professional. Him being back on board can only be a positive.

[beenthere]

That's great but it's coming from an investor who has been here for years and knows much about TLT. What would you think what a new investor  who would know very little about TLT think after reading this news? Would they be interested and dig deeper or think 3 years in the making .. maybe. I think I will pass!  At best  I might add it to my watch list.

[enriquesuave]

A new investor like us longs should think, that this MC is way too low given our accomplishments.  Compared to peers such as CGON, $2.6 Billion US,  IBRX, $ 2 Billion US, we could go up 50-100 times to catch up in MC value.  Short term catalysts are BTD, more data, Licensing agreements with Big Pharma. More preclinical data on GBM or NSCLC for XPDT which in of itself is a potential

[Benedictus]

Fully diluted market cap after recent issuance is roughly $68M. Any hoped for catalyst will likely bring all outstanding wts and opts itm since majority are priced at .35 or below, so best to account for the full share structure. While we'd all really like to see a peer comparable m/c for Theralase,  the reality is those peers went to market with strong VC funding leading to

[gebremeskel]

I guess we better cash in our chips fellas. It turns out that Theralase partnering with a big pharma is only an "outlier event" - devoutly to be wished but unlikely in the extreme!  And this comes straight from the pen of the Venerable Benedictus himself! Ah me, Bennie why don't you come right out and say it. Theralase shareholders are screwed! But of course no one should

[Benedictus]

Another predictable smarmy shoot the messenger post from the gerber playbook. Your us against the naysayers tone is petty and tiresome.  If you don't  care to read my posts then simply ignore them as many others here have thankfully chosen to do. I imagine it's the ongoing frustration longs have that causes such rude intolerance of any poster who doesn't toe the party line

[DeathXray33]

Take the G out of CGON. LOL...